Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Emergent BioSolutions Inc EBS

Healthcare Biotechnology
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a Bioservices portfolio. Its segments include Commercial Products, MCM Products, and Services Segment. Commercial... see more

Current News (NYSE:EBS)

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

GlobeNewswire 19 hours ago

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

GlobeNewswire 5 days ago

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

GlobeNewswire 6 days ago

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

GlobeNewswire 8 days ago

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire March 3, 2025

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

GlobeNewswire February 18, 2025

Emergent BioSolutions and Pro Football Legend Emmitt Smith Raise Awareness of Ready to Rescue Campaign Timed to the Big Game in New Orleans

GlobeNewswire February 7, 2025

Enrollment Starts in Africa CDC-Led MpOx Therapeutic Study (MOSA)

GlobeNewswire January 16, 2025

Emergent BioSolutions Gains Exclusive Commercial Rights to KLOXXADO® (naloxone HCI) Nasal Spray from Hikma Pharmaceuticals

GlobeNewswire January 14, 2025
View More News ››

Opinion & Analysis (NYSE:EBS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NYSE:EBS)

EBS California to Require narcan be at all businesses in the

EBS California to Require narcan be at all businesses in the state singed into law mins ago This should go nationwide to help save lives
10QKing - September 30, 2024

BUY BUY BUY BUY BUY

There yoy have it fellows day traders the winner for today
Nibinator - August 30, 2024

BUY BUY BUY BUY BUY

Sky rocketed since May to 600% i think it will continue to 20$ 24$
Nibinator - July 25, 2024

Emergent BioSolutions Launches Opioid Emergency Preparedness

NEWS: $EBS Emergent BioSolutions Launches Opioid Emergency Preparedness 'Lay, Spray, Stay' Public Education Campaign Starring...
whytestocks - July 24, 2024

Emergent BioSolutions to Release Second Quarter 2024 Financi

NEWS: $EBS Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6...
whytestocks - July 23, 2024

Emergent BioSolutions Announces Sale of Baltimore-Camden Man

BREAKING NEWS: $EBS Emergent BioSolutions Announces Sale of Baltimore-Camden Manufacturing Site to Bora Pharmaceuticals for $30 Million ...
whytestocks - June 20, 2024
View more Bullboard ››

Tidal Care Inc.

Tidal Care Inc.

Tidal Care aims to be a high-compliance supplier of finished, formulated Psilocybin- and MDMA-based drug products to the ...
View More »